Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GreenWave Extracts is a life sciences company focused on the development and commercialization of hemp-derived cannabinoid formulations. Based in Florida, the company specializes in advanced extraction techniques to produce high-purity CBD and other phytocannabinoids for the wellness and healthcare sectors. Their product line includes a variety of delivery formats such as oils, topicals, and capsules, targeting indications like chronic pain, anxiety, and sleep disorders. GreenWave Extracts emphasizes rigorous quality control and third-party laboratory testing to ensure the safety and potency of its botanical extracts. The company utilizes CO2 extraction technology to maintain the integrity of the plant's natural compounds while removing unwanted impurities. By serving both retail and wholesale markets, GreenWave Extracts has established itself as a provider of consistent, pharmaceutical-grade hemp products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GreenWave Extracts.